TUBB4B
MOLECULAR TARGETtubulin beta 4B class IVb
TUBB4B (tubulin beta 4B class IVb) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TUBB4B
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Colchicine | 4.93 | 138 |
| 2 | Nocodazole Nocodazole is | 3.37 | 28 |
| 3 | Podophyllotoxin | 2.94 | 18 |
| 4 | Vincristine | 2.56 | 12 |
| 5 | Noscapine | 1.10 | 2 |
| 6 | Demecolcine | 0.69 | 1 |
| 7 | Maytansine | 0.69 | 1 |
| 8 | vinblastine sulfate | 0.69 | 1 |
| 9 | Vorinostat | 0.69 | 1 |
About TUBB4B as a Drug Target
TUBB4B (tubulin beta 4B class IVb) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TUBB4B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TUBB4B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.